These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37853797)

  • 1. Unpublished trials of alprazolam XR and their influence on its apparent efficacy for panic disorder.
    Ahn-Horst RY; Turner EH
    Psychol Med; 2024 Apr; 54(5):1026-1033. PubMed ID: 37853797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.
    Moylan S; Staples J; Ward SA; Rogerson J; Stein DJ; Berk M
    J Clin Psychopharmacol; 2011 Oct; 31(5):647-52. PubMed ID: 21869686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database.
    Turner EH; Knoepflmacher D; Shapley L
    PLoS Med; 2012; 9(3):e1001189. PubMed ID: 22448149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
    Jonas JM; Cohon MS
    J Clin Psychiatry; 1993 Oct; 54 Suppl():25-45; discussion 46-8. PubMed ID: 8262888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alprazolam extended-release in panic disorder.
    Rickels K
    Expert Opin Pharmacother; 2004 Jul; 5(7):1599-611. PubMed ID: 15212610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
    Klein E
    J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients.
    Ravaris CL; Friedman MJ; Hauri PJ; McHugo GJ
    J Clin Psychopharmacol; 1991 Dec; 11(6):344-50. PubMed ID: 1770152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of Alprazolam Use, Misuse, and Withdrawal.
    Ait-Daoud N; Hamby AS; Sharma S; Blevins D
    J Addict Med; 2018; 12(1):4-10. PubMed ID: 28777203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporting Bias in Clinical Trials Investigating the Efficacy of Second-Generation Antidepressants in the Treatment of Anxiety Disorders: A Report of 2 Meta-analyses.
    Roest AM; de Jonge P; Williams CD; de Vries YA; Schoevers RA; Turner EH
    JAMA Psychiatry; 2015 May; 72(5):500-10. PubMed ID: 25806940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of benzodiazepines in panic disorder.
    Davidson JR
    J Clin Psychiatry; 1997; 58 Suppl 2():26-8; discussion 29-31. PubMed ID: 9078991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepines versus placebo for panic disorder in adults.
    Breilmann J; Girlanda F; Guaiana G; Barbui C; Cipriani A; Castellazzi M; Bighelli I; Davies SJ; Furukawa TA; Koesters M
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD010677. PubMed ID: 30921478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
    Klein E; Colin V; Stolk J; Lenox RH
    Am J Psychiatry; 1994 Dec; 151(12):1760-6. PubMed ID: 7977882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy studies of alprazolam in panic disorder.
    Spiegel DA
    Psychopharmacol Bull; 1998; 34(2):191-5. PubMed ID: 9640999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diazepam versus alprazolam for the treatment of panic disorder.
    Noyes R; Burrows GD; Reich JH; Judd FK; Garvey MJ; Norman TR; Cook BL; Marriott P
    J Clin Psychiatry; 1996 Aug; 57(8):349-55. PubMed ID: 8752017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanax XR for panic disorder.
    Med Lett Drugs Ther; 2003 May; 45(1157):43-4. PubMed ID: 12766702
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination of psychotherapy and benzodiazepines versus either therapy alone for panic disorder: a systematic review.
    Watanabe N; Churchill R; Furukawa TA
    BMC Psychiatry; 2007 May; 7():18. PubMed ID: 17501985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic-pituitary-adrenal axis activity in panic disorder: effects of alprazolam on 24 h secretion of adrenocorticotropin and cortisol.
    Abelson JL; Curtis GC; Cameron OG
    J Psychiatr Res; 1996; 30(2):79-93. PubMed ID: 8816303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled study.
    Sheehan DV; Raj AB; Harnett-Sheehan K; Soto S; Knapp E
    Acta Psychiatr Scand; 1993 Jul; 88(1):1-11. PubMed ID: 8372689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of neuropsychologic deficits in patients receiving long-term treatment with alprazolam-XR for panic disorder.
    Gladsjo JA; Rapaport MH; McKinney R; Auerbach M; Hahn T; Rabin A; Oliver T; Haze A; Judd LL
    J Clin Psychopharmacol; 2001 Apr; 21(2):131-8. PubMed ID: 11270908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.